Filing Flows › Staar Surgical (STAA) › Q4 2025
Staar Surgical (STAA) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 3, 2026
Staar Surgical (STAA) reported revenue of $57.8M for the fourth quarter 2025 (Q4 2025), +18% from a year earlier and -39% from the quarter before. Operating margin was -39.5%, net loss $18.3M (31.7% of revenue).
Staar Surgical, Q4 2025: revenue $57.8M (+18% year over year), operating margin -39.5%, net loss $18.3M, operating cash flow −$3.9M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $57.8M | -39% | +18% |
| Operating profit | −$22.8M | -224% | — |
| Net earnings | −$18.3M | -306% | — |
| Operating cash flow | −$3.9M | -247% | — |
What changed
Revenue was $57.8M in Q4 2025, up 18% year over year and down 39% from the previous quarter.
Gross margin was 75.7%, up 11.0 points from a year earlier. Operating costs exceeded revenue by $22.8M, an operating margin of -39.5%. Operating expenses grew 12% against revenue growth of 18%. The quarter ended with a net loss of $18.3M, after a profit of $8.9M the previous quarter.
Operating cash flow was −$3.9M. Non-cash charges added back $2.0M of depreciation and $8.6M of share-based compensation. Working capital and other items added $3.8M. Capital expenditures of $1.7M exceeded it, leaving free cash flow of −$5.6M.
Questions
What was Staar Surgical's revenue in the fourth quarter 2025?
Staar Surgical (STAA) reported revenue of $57.8M for the fourth quarter 2025 (Q4 2025), +18% from a year earlier and -39% from the quarter before.
Was Staar Surgical profitable in the fourth quarter 2025?
Operating loss was $22.8M (-39.5% of revenue) and net loss $18.3M.
Source: Staar Surgical 10-K on SEC EDGAR.